-
1
-
2
-
3
-
4
-
5
-
6
Alpha-diversity compared between involved and non-involved sites.
Julkaistu 2023Aiheet: “…nodular bronchiectatic form…”
-
7
-
8
-
9
Logic forms for the interactions involved in the drug mechanism domain.
Julkaistu 2012“…<p>Logic forms for the interactions involved in the drug mechanism domain.…”
-
10
-
11
-
12
PIK3C3 is not involved in the formation of PtdIns(3)P at the inner membrane of protrusions.
Julkaistu 2025Aiheet: -
13
The proportion of residues typically involved in forming secondary structure of the protein.
Julkaistu 2025“…<p>The proportion of residues typically involved in forming secondary structure of the protein.…”
-
14
Logic forms for the classes and entities involved in the drug mechanism domain.
Julkaistu 2012“…<p>Logic forms for the classes and entities involved in the drug mechanism domain.…”
-
15
-
16
Proportions of <i>Mycobacterium</i> compared between involved and non-involved sites in study patients (n = 23).
Julkaistu 2023Aiheet: “…nodular bronchiectatic form…”
-
17
Precatalysts Involved in Copper-Catalyzed Arylations of Nucleophiles
Julkaistu 2007“…In this work, we synthesized a precatalyst involving one of the best ligands of the literature, the tetradentate chelator <b>1</b>, and characterized it at the solid state and in solution (NMR, electrochemistry, X-ray crystallography). …”
-
18
-
19
Relative proportions of phyla and genera of lung microbiomes compared between involved and non-involved sites (taxa <1% are not indicated).
Julkaistu 2023Aiheet: “…nodular bronchiectatic form…”
-
20
Taxonomic biomarker analysis for phyla and genera compared between involved and non-involved sites in study patients (n = 23).
Julkaistu 2023Aiheet: “…nodular bronchiectatic form…”